Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Clinical trial NCT01475162 · TERMINATED
Trial details
- NCT number
- NCT01475162
- Sponsor
- Medical College of Wisconsin
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-08
- Primary completion
- 2016-02-17
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.